If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,798.00    8.00 (0.45%)
Bid:
1,796.00
Ask:
1,802.00
Spread: 6.00 (0.334%)
Market Cap: £529.54m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

CEO Succession Update

30 Sep 2022 07:00

RNS Number : 2478B
Avon Protection PLC
30 September 2022
 

30 September 2022

Avon Protection plc

("Avon Protection" or "the Group")

CEO succession update

As set out in the announcement on 24 May 2022, Paul McDonald today steps down from his role as Chief Executive Officer (CEO). The Board is well advanced in the recruitment process for his successor, led by the Nomination Committee with the support of external consultants. In order to ensure executive continuity whilst this selection process is concluded, Bruce Thompson, currently Non-Executive Chair, will become Executive Chair, with effect from 1 October until a new CEO is in place. As a result of this change, Bruce will step down from his role on the Remuneration Committee during this period.

Bruce joined Avon Protection as Non-Executive Chair Designate in March 2020, having previously been Chief Executive Officer of Diploma PLC, the FTSE 250 specialised technical products and services business, for over twenty years.

The Board will make a further announcement regarding the appointment of a new CEO in due course.

For further enquiries, please contact:

Avon Protection

 

Bruce Thompson, Executive Chairman

+44 1225 896 848

Rich Cashin, Chief Financial Officer

 

Rory Wiltshire, Investor Relations Manager

 

 

MHP Communications

 

Andrew Jaques

+44 771 003 2657

Charlie Barker

avonprotection@mhpc.com

Pete Lambie

 

 

Note to editors:

Avon Protection designs and produces life-critical personal protection solutions for the world's militaries and first responders. With a portfolio that includes Chemical, Biological, Radiological, Nuclear ("CBRN"), respiratory and head protection products, our mission is to enhance the performance, efficiency and capability of our customers whilst providing ever increasing levels of protection.

Avon Protection operates from six sites employing approximately 1,000 people and is listed on the London Stock Exchange (LSE: AVON).

For further information, please visit our website www.avon-protection-plc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALLMRTMTTTBFT
Date   Source Headline
1st Feb 20183:58 pmRNSResult of AGM
1st Feb 20187:00 amRNSAGM Statement
29th Jan 20187:00 amRNSUS Department of Defense Mask Systems Order
24th Jan 20185:38 pmRNSHolding(s) in Company
24th Jan 201811:44 amRNSHolding(s) in Company
9th Jan 20188:52 amRNSDirector/PDMR Shareholding
20th Dec 201712:16 pmRNSHolding(s) in Company
18th Dec 201710:18 amRNSNotice of Annual Report and Accounts and AGM
6th Dec 20173:39 pmRNSDirector/PDMR Shareholding
6th Dec 20172:14 pmRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSUS Department of Defense Mask Systems Order
30th Nov 20174:20 pmRNSDirector/PDMR Shareholding
29th Nov 201711:10 amRNSDirector/PDMR Shareholding
24th Nov 20174:39 pmRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSFinal Results
8th Nov 20177:00 amRNSAward of US JE-RDAP CBRNe framework contract
7th Nov 201712:15 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:30 pmRNSPreferred bidder nomination
6th Oct 20173:42 pmRNSDirector/PDMR Shareholding
20th Sep 20175:01 pmRNSHolding(s) in Company
15th Sep 20177:00 amRNSPre-close trading update
12th Sep 20179:13 amRNSDirector/PDMR Shareholding
8th Sep 20179:07 amRNSDirector/PDMR Shareholding
4th Sep 201711:06 amRNSHolding(s) in Company
31st Aug 20174:08 pmRNSDirector/PDMR Shareholding
21st Aug 20172:06 pmRNSHolding(s) in Company
21st Aug 20171:53 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAppointment of Corporate Broker
14th Aug 20179:59 amRNSDirector/PDMR Shareholding
9th Aug 201710:16 amRNSDirector/PDMR Shareholding
8th Aug 20173:33 pmRNSDirector/PDMR Shareholding
8th Aug 20171:23 pmRNSHolding(s) in Company
31st Jul 201711:03 amRNSDirector/PDMR Shareholding
6th Jul 20171:18 pmRNSDirectors'/PDMR Shareholdings - SIP
6th Jun 201711:51 amRNSDirector/PDMR Shareholding
23rd May 20177:00 amRNSContract Award
16th May 20177:00 amRNSHalf-year Report
10th May 20177:00 amRNSDirectorate Change
8th May 201712:31 pmRNSDirector/PDMR Shareholding
6th Apr 20174:03 pmRNSDirector/PDMR Shareholding
7th Mar 201710:34 amRNSDirector/PDMR Shareholding
17th Feb 20175:45 pmRNSHolding(s) in Company
15th Feb 20172:34 pmRNSDirector/PDMR Shareholding
15th Feb 20177:00 amRNSDirectorate Change
8th Feb 20174:11 pmRNSDirector/PDMR Shareholding
3rd Feb 20175:22 pmRNSHolding(s) in Company
2nd Feb 20175:13 pmRNSResult of AGM
2nd Feb 20177:00 amRNSTrading Update
26th Jan 20179:37 amRNSHolding(s) in Company
9th Jan 201710:20 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.